The Department of Biotechnology under the Ministry of Science and Technology has launched 'Mission COVID Suraksha- the Indian COVID-19 Vaccine Development Mission'.
"If an Indian citizen beneficiary has taken first dose of Covishield or AstraZeneca (ChAdOx1 nCov-19) vaccine outside India, the beneficiary can register on CoWIN app at the time of taking the second dose of Covishield vaccine after prescribed time interval and details of first dose can be recorded on the CoWIN app at the same time."
The State Health Department of Odisha has requested the Centre to allocate the balance Covid vaccine doses under private hospitals share to the State government.
The State government of Odisha on Friday announced to introduce Covaxin for inoculation of people aged 18 years and above in the district of Ganjam. Manufactured by the Bharat Biotech will be soon rolled out for vaccinating people in Ganjam district including the Berhampur Municipal Corporation area from the month of July.
The Odisha government on Wednesday stopped the COVID-19 vaccination drive in 11 districts due to an "acute shortage" of Covishield doses
The State Health Department of Odisha has appealed to the people to take Covid-19 vaccine shot as early as possible and adhere to the appropriate Covid protocols ahead of a possible third wave of the pandemic that has already hit other countries.
As per experts, a vaccine will be considered a marathoner protector if it is able to produce good spike protein antibodies. A spike protein antibody test can confirm whether claims made by Covisheild and Covaxin are true
On the decision to increase the gap between two doses of Covishield from four-six weeks to 12-16 weeks, he said the move was based on scientific decision and there was no dissenting voice among the National Technical Advisory Group on Immunisation (NTAGI) members.
The maximum price of Covishield for private COVID-19 Vaccination Centres (CVCs) has been fixed at Rs 780 per dose, while that of Covaxin is Rs 1,410 per dose and Sputnik V Rs 1,145 per dose, it said.
Noting that 60 per cent to 70 per cent of the children who got infected and got admitted in hospitals during the second wave in India, had either comorbidities or low immunity, the All India Institute of Medical Sciences (AIIMS) Director said that healthy children recovered with mild illness without need for hospitalisation.
The series of lockdowns and shutdowns enforced by the State government of Odisha has really fructified results as anticipated, DMET CBK Mohanty said today.
A latest study has found that both vaccines, Covishield and Covaxin elicited a good immune response after two doses, although seropositivity rates and the median anti-spike antibody titre was significantly higher in Covishield as compared to Covaxin.
Vaccine manufacturer, Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking permission to manufacture Russian COVID vaccine Sputnik V in India. As per sources, the Pune-based vaccine maker has also sought permission for test analysis and examination.
The Odisha Health and Family Welfare Department on Wednesday issued advisory for the physicians and beneficiaries to report suspected Thrombosis after Covishield vaccine administration.
The Union government has reiterated to the states/UTs that online appointments booked for second dose of Covishield prior to this change of the interval between the two doses of Covishield, must be honoured.
Gap between two doses of Covishield vaccine increased. A day after the Union Health ministry increased the gap between 2 doses of Covishield, Odisha announced the changes. Union Health Ministry widened the gap between 2 doses of Covishield from 42 days (6 weeks) to 84 days
The Ministry of Health and Family Welfare (MoHFW) had on Thursday widened the gap between two doses of Serum Institute of India’s Covidshield vaccine from 42 days (6 weeks) to 84 days (12weeks).
The Centre on Thursday approved extending the gap between the two doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks.
A government panel has recommended increasing the gap between two doses of Covishield COVID-19 vaccine to 12-16 weeks and said that pregnant women may be offered the choice to take any vaccine
The Centre has told the Supreme Court that no governmental aid, assistance or grant was made either for research or development of either Covaxin or Covishield vaccines but some financial assistance was given for conducting clinical trials.
Bhubaneswar: Amid a shortage of vaccines in Odisha, the State government on Monday put persons eligible for 2nd dose of Covishield vaccine on a priority list. A notification in this…
Bhubaneswar: To ensure second dose of vaccine to people aged 45 years and above, the Odisha government on Friday asked the Centre to urgently supply at least 25 lakh doses…
London: A single dose of a Pfizer or AstraZeneca vaccine against coronavirus disease can reduce transmission by up to 50 per cent, finds a study. The study led by UK’s…
New Delhi: Serum Institute of India (SII) — the maker of the most used COVID-19 vaccine in the country — on Wednesday announced a cut in price of the jab…
Bhubaneswar: Voices of dissent have grown louder within the private medical community and political corridors in Odisha against the disparity in the prices of vaccine in Private and Government run…